How Safe Is Abbott Labs' Dividend?
Abbott Laboratories (NYSE: ABT) has a long history of serving the healthcare community with its products. For much of its history, Abbott was a true healthcare conglomerate, producing both pharmaceuticals and medical devices to serve a large patient population. With the company's spinoff of its proprietary pharmaceutical business into AbbVie (NYSE: ABBV), the continuing Abbott Labs now focuses on medical devices and generic pharmaceuticals. That focus hasn't prevented the stock from hitting new all-time record highs, but it has raised questions from time to time about whether the dividend growth that Abbott enjoyed in the past is sustainable for the more-focused company going forward. Let's take a closer look at Abbott Labs to see whether investors can be confident in its ability to keep its dividend moving higher.
Current Quarterly Dividend Per Share
$0.265
Source: Fool.com
Abbott Laboratories Aktie
Deutliche Buy-Präferenz bei Abbott Laboratories ohne Sell-Einschätzungen.
Das Kursziel von 116 € für Abbott Laboratories weist auf eine leichte Verbesserung gegenüber dem aktuellen Kurs von 105.22 € hin.
